A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects. Known for anxiolytic properties without sedation.

Is Selank FDA approved?

No, Selank is not FDA approved. Current status: Approved in Russia - Not FDA approved

What are the side effects of Selank?

Reported side effects of Selank include: Generally well-tolerated, Nasal irritation (spray), Headache, Nausea, Fatigue, Non-sedative and non-addictive, May enhance effects of benzodiazepines, Approved in Russia for anxiety.

What is the typical dosing for Selank?

Doses from clinical practice. Common doses observed in research: 250-500 mcg intranasal, Up to 3x daily. Duration: 14-21 days typical. Administration: Intranasal spray (most common), subcutaneous injection.

Cognitive

Selank

Also known as: Selanc, TP-7

Clinical Trials

Popular For

Anxiety relief, focus, stress reduction, cognitive clarity

Key Facts: Selank

Category: Cognitive
FDA Status: Not FDA Approved
Clinical Status: Approved in Russia - Not FDA approved
Administration: Intranasal spray (most common), subcutaneous injection
Typical Dose: 250-500 mcg intranasal 2-3x daily
Frequency: 2-3x daily, intranasal
Evidence Level: Human Trials
Duration: 14-21 days typical

Also Known As

Selanc, TP-7

Mechanism of Action

Selank modulates the expression of BDNF (brain-derived neurotrophic factor), influences serotonin and dopamine metabolism, and has effects on the GABAergic system. It also has immunomodulatory properties inherited from its tuftsin backbone.

Research Summary

Russian clinical trials demonstrate anxiolytic effects comparable to benzodiazepines without sedation or addiction potential. Studies show improved cognitive function under stress, enhanced memory, and stabilization of mood.

Clinical Status:Approved in Russia - Not FDA approved

Trial Progress:FDA Approved

Pre

III

FDA

Dosing Information

Human Trials·Human studies conducted, not FDA approved

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

250-500 mcg intranasal 2-3x daily

Range

200-750 mcg per dose

Frequency

2-3x daily, intranasal

Anxiolytic nootropic. Used intranasally. Effects build over days/weeks. Often stacked with Semax.

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

Doses from clinical practice

Doses from Studies

250-500 mcg intranasal

Research Literature - Observed in studies ↗

Up to 3x daily

Research Literature - Observed in studies ↗

Duration

14-21 days typical

Administration

Intranasal spray (most common), subcutaneous injection

Timing & Administration

Best Time to Take

Morning or as needed for anxiety

2-3 times daily as needed

Food Recommendation

With or without food

Why This Timing?

Selank has anxiolytic effects without sedation. Morning use helps manage daytime stress and anxiety.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Generally well-tolerated
●Nasal irritation (spray)
●Headache
●Nausea
●Fatigue
●Non-sedative and non-addictive
●May enhance effects of benzodiazepines
●Approved in Russia for anxiety

References

Related Peptides

Peptides commonly compared with Selank or used in similar applications.

Semax

Clinical Trials

A synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.

Cognitive

Cerebrolysin

Clinical Trials

A mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.

Cognitive

Dihexa

Preclinical

A potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.

Cognitive

GB-115

Clinical Trials

A dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Developed in Russia with completed Phase 3 trials for anxiety. Users report significant improvements in focus, attention, and ADHD-like symptoms.

Cognitive

Normoftal

Clinical Trials

A synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. Developed to normalize retinal function and support eye health. Clinical studies in Russia report improved visual function in 95% of patients with various retinal pathologies.

Cognitive

P21

Preclinical

A synthetic peptide mimetic of CNTF (ciliary neurotrophic factor) designed for neurodegenerative disease. Promotes neurogenesis and reduces neuroinflammation.

Cognitive

How to Use Selank Selank Alternatives Compare with Similar Browse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors

PRO

Want updates on Selank research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.

Back to all peptides